From the Journals

New vascular 0 + 5 training programs yield fewer PAD cases


 

FROM SURGERY

The new vascular surgery training protocol may not reflect what is currently occurring in practice for peripheral artery occlusive disease, and may warrant further investigation, according to a study performed by John Phair, MD, and his colleagues.

© danr13/iStockphoto

“Peripheral arterial occlusive disease constitutes a substantial portion of clinical practice in vascular surgery and, as such, trainees must graduate with proficiency in endovascular and open procedures to become capable vascular surgeons,” they stated, but the new paradigm does not appear to be reflecting that reality.

The researchers compared case volume for 0 + 5 integrated vascular surgery residents (IVSR) in the chief and junior years with their 5 + 2 fellowship counterparts (VSF) for the treatment of peripheral arterial occlusive disease. An aggregate of 887 residents and fellows from 137 programs were identified. From 2012 to 2018, VSFs performed significantly more total peripheral procedures than IVSR surgeon chiefs in the treatment of peripheral arterial occlusive disease, with VSFs consistently performing 1.7-fold (P less than .001) and 1.6-fold (P less than .001) more total peripheral cases than their integrated vascular surgery residents chief and junior counterparts, respectively. When stratified by anatomic location, VSFs were found to have performed more peripheral arterial procedures in the aortoiliac, femoropopliteal, and infrapopliteal arteries, compared with IVSR chiefs, and they also performed more total peripheral procedures than IVSR surgeon juniors, the authors reported online in the journal Surgery (2019 E-pub; doi/10.1016/j.surg.2019.02.021).

“Although both training paradigms offer operative experiences that meet criteria for graduation, it seems that VSFs currently perform more endovascular and open cases than their IVSR counterparts for peripheral arterial occlusive disease during the final phase of training. These findings may be contradictory to current thinking regarding the vascular surgery training paradigms,” the researchers concluded.

There were no disclosures reported.

SOURCE: Phari J et al. Surgery 2019 E-pub; doi/10.1016/j.surg.2019.02.021).

Recommended Reading

Multiple factors predict surgical site infection risk after lower extremity revascularization
MDedge Surgery
Medicaid expansion meant earlier presentation, better surgical outcomes
MDedge Surgery
Femoral artery endarterectomy still ‘gold standard’
MDedge Surgery
Fewer groin infections with closed incision negative pressure therapy after vascular surgery
MDedge Surgery
Tracking 90-day vascular surgery outcomes: The coming new normal?
MDedge Surgery
Claudication, CLI differ significantly in hospital readmission, costs, mortality
MDedge Surgery
Frailty tied to higher mortality after major vascular surgery
MDedge Surgery
Drug-coated balloon advantage persists in femoral artery disease
MDedge Surgery
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
MDedge Surgery
Ask patients, not devices, about impact of PAD
MDedge Surgery